Orasure Tech Inc (OSUR) Stock Price, Quote & News

Company Profile

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic and specimen collection devices and products in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rap...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 610 882 1820

Website: www.orasure.com

Address:

220 East First Street, Bethlehem, United States

JohnTrack Jan. 15 at 8:54 PM

$OSUR hovering this chart, chill!

0 · Reply

JohnTrack Jan. 15 at 6:48 PM

$OSUR small headline in the wild https://www.rapidticker.com/news/osur-altai-capital-management-nominates-two-d06bbc

0 · Reply

ZacksResearch Jan. 6 at 5:43 PM

$OSUR makes a regulatory move that could reshape its growth path 👀 OraSure just filed FDA applications for two at-home STI tests — a molecular self-test and the Colli-Pee device — pushing deeper into decentralized diagnostics, with shares up 3.8% on the news. Is this a long-term growth inflection? Full details here 👉 https://www.zacks.com/stock/news/2812722/orasure-files-for-fda-review-of-molecular-self-test-colli-pee-device?cid=sm-stocktwits-2-2812722-teaser-27612&ADID=SYND_STOCKTWITS_TWEET_2_2812722_TEASER_27612

0 · Reply

ZacksResearch Jan. 6 at 4:43 PM

$OSUR gains 3.8% on FDA submission news — a turning point? 🚀 OraSure Technologies filed for FDA approval on two at-home STI tests, aiming to decentralize diagnostics and tap into the $1.5B CT/NG testing market, which is currently dominated by centralized labs. Long-term, this could bolster recurring revenues and expand its market reach. Discover the growth potential here 👉 https://www.zacks.com/stock/news/2812722/orasure-files-for-fda-review-of-molecular-self-test-colli-pee-device?cid=sm-stocktwits-2-2812722-body-27595&ADID=SYND_STOCKTWITS_TWEET_2_2812722_BODY_27595

0 · Reply

JohnTrack Jan. 6 at 2:50 AM

$OSUR monitoring ladder builds!

0 · Reply

JohnTrack Jan. 5 at 11:49 PM

$OSUR Submits CT/NG Molecular Self-Test and Colli-Pee Urine Collection Device for FDA Review https://www.rapidticker.com/news/osur-sec-filing-177d66

0 · Reply

DARKP00L Jan. 5 at 1:22 PM

$OSUR 08:04 on Jan. 05 2026 OraSure Submits Two Separate Applications At 2025 End To FDA For Clearance Of Rapid Molecular Self-Test For CT/NG As Well As Colli-Pee At-Home Urine Collection Device For STIs #tradeideas

1 · Reply

BillionerOfKing Jan. 1 at 5:13 AM

$OSUR Current Stock Price: $2.42 Contracts to trade: $2.5 OSUR Jan 16 2026 Call Entry: $0.10 Exit: $0.19 ROI: 89% Hold ~27 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

FeldsparFly Dec. 27 at 4:34 AM

$OSUR Risk appetite is present but conditioned on validation. Competitive differentiation has to become evident in core KPIs. Risk compresses once delivery patterns become predictable. Stronger outcomes appear only when priorities stay focused.

0 · Reply

InclusionInsider Dec. 26 at 10:10 AM

$OSUR The thesis is evolving from vision-led to process-driven as scrutiny intensifies. Operational consistency must improve quarter by quarter. Sustained momentum may broaden institutional interest. Ultimately, this is a case where delivery will decide trajectory.

0 · Reply

OraSure Technologies Confirms Receipt of Director Nominations from Altai Capital

Jan 15, 2026, 8:30 AM EST - 1 day ago

Altai Capital Management Nominates Two Highly-Qualified Candidates for Election to OraSure Board of Directors

Dec 17, 2025, 1:23 PM EST - 4 weeks ago

OraSure Technologies Issues Statement Regarding Altai Capital's Intent to Nominate Director Candidates

Dec 17, 2025, 8:00 AM EST - 4 weeks ago

Altai Capital Management Announces Intention to Nominate Two Highly-Qualified Candidates for Election to OraSure Board of Directors

Nov 5, 2025, 8:11 PM EST - 2 months ago

OraSure Technologies, Inc. (OSUR) Q3 2025 Earnings Call Transcript

Oct 29, 2025, 7:30 AM EDT - 2 months ago

OraSure to Announce Third Quarter 2025 Financial Results and Host Earnings Call on November 5th

Oct 28, 2025, 4:22 PM EDT - 2 months ago

OraSure Technologies Appoints Steven K. Boyd to its Board of Directors

Sep 9, 2025, 6:19 AM EDT - 4 months ago

Exclusive: Altai Capital lays groundwork for board fight at OraSure Technologies, sources say

Aug 25, 2025, 12:12 PM EDT - 5 months ago

Exclusive: Healthcare entrepreneur's letter threatens 'adversarial path' after OraSure Tech rebuffs bid

Aug 5, 2025, 8:17 PM EDT - 5 months ago

OraSure Technologies, Inc. (OSUR) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 7:05 AM EDT - 5 months ago

OraSure Appoints Anne Messing as Chief Commercial Officer

Jul 28, 2025, 2:43 AM EDT - 6 months ago

OraSure Technologies: An Asymmetric Bet

Jul 21, 2025, 4:05 PM EDT - 6 months ago

OraSure to Announce Second Quarter 2025 Financial Results and Host Earnings Call on August 5th

Jul 14, 2025, 12:03 PM EDT - 6 months ago

OraSure Technologies received takeover bid from industry entrepreneur, sources say

Jul 10, 2025, 7:05 AM EDT - 6 months ago

OraSure Launches Novel Blood Collection Device for Proteomic Research

May 28, 2025, 10:25 AM EDT - 8 months ago

Orasure Technologies: Multiple Shots To Deliver Value

May 7, 2025, 8:01 PM EDT - 9 months ago

OraSure Technologies, Inc. (OSUR) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 3:47 PM EDT - 9 months ago

OraSure Technologies: Historically Cheap

Apr 23, 2025, 4:05 PM EDT - 9 months ago

OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th

Mar 24, 2025, 7:30 AM EDT - 10 months ago

OraSure Announces $40 Million Stock Repurchase Program

Feb 27, 2025, 5:49 AM EST - 11 months ago

OraSure Technologies, Inc. (OSUR) Q4 2024 Earnings Call Transcript

Feb 14, 2025, 8:45 AM EST - 1 year ago

OraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25th

Jan 13, 2025, 8:00 AM EST - 1 year ago

NOWDiagnostics Responds with Countersuit Against Frivolous OraSure Claims

Jan 7, 2025, 4:05 PM EST - 1 year ago

OraSure to Present at the J.P Morgan Healthcare Conference

Jan 7, 2025, 8:50 AM EST - 1 year ago

CORRECTION - OraQuick® HIV Self-Test Now Approved for Use in Adolescents

Jan 7, 2025, 7:05 AM EST - 1 year ago

OraQuick® HIV Self-Test Now Approved for Use in Adolescents

Dec 19, 2024, 4:02 PM EST - 1 year ago

OraSure Technologies Acquires Sherlock Biosciences

Dec 11, 2024, 1:34 PM EST - 1 year ago

OraSure Technologies: Discounted Assets With An Attractive Free Call Option

Dec 2, 2024, 7:05 AM EST - 1 year ago

OraSure Receives Federal Funding for Development of Marburg Virus Rapid Antigen Test

Nov 18, 2024, 4:05 PM EST - 1 year ago

OraSure to Participate in Upcoming Investor Conference

Nov 6, 2024, 11:05 PM EST - 1 year ago

OraSure Technologies, Inc. (OSUR) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 4:05 PM EST - 1 year ago

OraSure Reports Q3 '24 Revenue of $39.9 Million

Nov 4, 2024, 9:32 AM EST - 1 year ago

OraSure: An NCAV Diamond In The COVID Rough

Oct 22, 2024, 4:05 PM EDT - 1 year ago

OraSure to Announce Third Quarter 2024 Financial Results and Host Earnings Call on November 6th

Oct 4, 2024, 4:03 PM EDT - 1 year ago

Neuberger Berman Group LLC Expands Stake in OraSure Technologies Inc

Sep 9, 2024, 7:05 AM EDT - 1 year ago

OraSure Technologies Elects Jack Kenny to the Board of Directors

Aug 6, 2024, 9:04 PM EDT - 1 year ago

OraSure Technologies Inc (OSUR) Q2 2024 Earnings Call Transcript

Jul 22, 2024, 4:05 PM EDT - 1 year ago

OraSure to Announce Second Quarter 2024 Financial Results and Host Earnings Call on August 6th

Jun 27, 2024, 7:05 AM EDT - 1 year ago

OraSure Technologies Supports National HIV Testing Day

Apr 22, 2024, 8:00 AM EDT - 1 year ago

OraSure to Announce First Quarter 2024 Financial Results and Host Earnings Call on May 8th

Mar 21, 2024, 8:31 AM EDT - 1 year ago

NOWDiagnostics Welcomes Dr. Stephen S. Tang as Chairman of the Board

Feb 27, 2024, 10:16 PM EST - 2 years ago

OraSure Technologies, Inc. (OSUR) Q4 2023 Earnings Call Transcript

Feb 27, 2024, 4:05 PM EST - 2 years ago

OraSure Reports Q4 ‘23 Revenue of $75.9 Million

Feb 13, 2024, 4:05 PM EST - 2 years ago

OraSure to Announce Fourth Quarter 2023 Financial Results and Host Earnings Call on February 27th

Jan 4, 2024, 7:05 AM EST - 2 years ago

OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests in Sapphiros, a Next-Generation Consumer Diagnostics Company

Nov 13, 2023, 4:15 PM EST - 2 years ago

OraSure to Participate in Upcoming Investor Conferences

Nov 7, 2023, 7:20 PM EST - 2 years ago

OraSure Technologies, Inc. (OSUR) Q3 2023 Earnings Call Transcript

Oct 23, 2023, 4:05 PM EDT - 2 years ago

OraSure to Announce Third Quarter 2023 Financial Results and Host Earnings Call on November 7th

Aug 3, 2023, 11:10 PM EDT - 2 years ago

OraSure Technologies, Inc. (OSUR) Q2 2023 Earnings Call Transcript

Aug 3, 2023, 4:05 PM EDT - 2 years ago

OraSure Reports Q2 ‘23 Revenue of $85.4 Million; Core Revenue Grows 3% Year-over-Year

JohnTrack Jan. 15 at 8:54 PM

$OSUR hovering this chart, chill!

0 · Reply

JohnTrack Jan. 15 at 6:48 PM

$OSUR small headline in the wild https://www.rapidticker.com/news/osur-altai-capital-management-nominates-two-d06bbc

0 · Reply

ZacksResearch Jan. 6 at 5:43 PM

0 · Reply

ZacksResearch Jan. 6 at 4:43 PM

0 · Reply

JohnTrack Jan. 6 at 2:50 AM

$OSUR monitoring ladder builds!

0 · Reply

JohnTrack Jan. 5 at 11:49 PM

$OSUR Submits CT/NG Molecular Self-Test and Colli-Pee Urine Collection Device for FDA Review https://www.rapidticker.com/news/osur-sec-filing-177d66

0 · Reply

DARKP00L Jan. 5 at 1:22 PM

1 · Reply

BillionerOfKing Jan. 1 at 5:13 AM

0 · Reply

FeldsparFly Dec. 27 at 4:34 AM

0 · Reply

InclusionInsider Dec. 26 at 10:10 AM

0 · Reply

SuperGreenToday Dec. 19 at 7:02 PM

$OSUR Share Price: $2.38 Contract Selected: Jul 17, 2026 $2.5 Calls Buy Zone: $0.26 – $0.32 Target Zone: $0.44 – $0.54 Potential Upside: 63% ROI Time to Expiration: 209 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Love1010 Dec. 17 at 7:44 PM

$OSUR @Gantz7 <----- this guy is a complete tool. Doesn't have a clue how stocks work.

0 · Reply

Gantz7 Dec. 17 at 5:30 PM

$OSUR Altai Capital making movement on getting there own choice for the board....

1 · Reply

clairemurphy05 Dec. 11 at 7:53 PM

$OSUR Mainz Biomed is holding the same 1.04–1.05 floor for multiple sessions, no new lows, that’s quiet accumulation at the bottom in my playbook, I’m just waiting for the first abnormal volume bar to hit

0 · Reply

deepthinker Nov. 19 at 5:12 PM

$OSUR This obviously will go to zero if activists can’t force an acquisition. It’s going to be a heck of a fight to stop the destruction of this company, though.

0 · Reply

deepthinker Nov. 18 at 7:42 PM

$OSUR CEO and BoD. That’s your money.

0 · Reply

deepthinker Nov. 18 at 7:38 PM

$OSUR One handle this week? But, $4 is undervalued.

0 · Reply

deepthinker Nov. 18 at 5:35 PM

$OSUR Penny stock status and delisting await. Let’s “refresh” the BoD, and by refresh I mean give tons of comp to hopeless losers who will guarantee Ellington Outhouse Henhouse Doghouse Manner’s complete destruction of the company. She/her, you go girl!

0 · Reply

deepthinker Nov. 18 at 5:29 PM

$OSUR Any board member who voted against $4 must resign immediately!!!

0 · Reply

deepthinker Nov. 18 at 5:27 PM

$OSUR “$4 is undervalued. How dare you.”

0 · Reply

Dumass Nov. 18 at 3:55 PM

$OSUR Hoping gagnon is smart because right now I'm gaggin on a loss

1 · Reply

deepthinker Nov. 18 at 3:28 PM

$OSUR Trapped in DEI hell.

0 · Reply

Market Cap	196.55M
Revenue (ttm)	185.83M
Net Income (ttm)	-19.50M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-10.49%
Debt to Equity Ratio	0.00

Volume	313,500
Avg Vol	728,232
Day's Range	N/A - N/A
Shares Out	71.73M
Stochastic %K	70%
Beta	0.77
Analysts	Hold
Price Target	$3.00